AMGN

NASDAQ · Biotechnology

Amgen Inc

S&P 500 Nasdaq 100 Dow Jones Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$326.31

-9.92 (-2.95%)

As of May 16, 1:00 AM ET ·

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 21 48%

Hold 20 45%

Sell 3 7%

Price Target

Analyst Price Target -41.5% upside

Low Target $141.50

Average Target $190.87

High Target $279.75

Current Price $326.31

Current
$326.31

Target
$190.87

$141.50 $190.87 avg $279.75

Scenario Analysis

Bear Case

$141.50

-56.6%

Low target

Base Case

$190.87

-41.5%

Avg target

Bull Case

$279.75

+-14.3%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$391.29

-16.6% from high

52-Week Low

$261.43

+24.8% from low

50-Day SMA

$340.27

-4.1% vs SMA

200-Day SMA

$306.48

+6.5% vs SMA

RSI (14)

67.1

Neutral

Target vs 52W High

$190.87

-51.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%